Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of Thorne Healthtech, Inc. from 31 Dec 2019 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Thorne Healthtech, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Dec 2019 to 30 Jun 2023.
  • Thorne Healthtech, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Jun 2023 was $155,255,103, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

Thorne Healthtech, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $155,255,103 +$30,167,831 +24% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $148,945,577 +$21,132,246 +17% 31 Mar 2023 10-Q 09 Aug 2023 2023 Q2
Q4 2022 $146,651,814 +$28,319,337 +24% 31 Dec 2022 10-Q 09 Aug 2023 2023 Q2
Q3 2022 $131,923,178 +$18,347,958 +16% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $125,087,272 +$206,806,155 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $127,813,331 +$209,432,658 31 Mar 2022 10-Q 09 Aug 2023 2023 Q2
Q4 2021 $118,332,477 +$205,168,816 31 Dec 2021 10-Q 09 Aug 2023 2023 Q2
Q3 2021 $113,575,220 +$198,862,544 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $81,718,883 +$30,951,032 +27% 30 Jun 2021 10-Q 10 Nov 2022 2022 Q3
Q1 2021 $81,619,327 31 Mar 2021 10-Q 10 Aug 2022 2022 Q2
Q4 2020 $86,836,339 +$20,081,246 +19% 31 Dec 2020 10-K 31 Mar 2023 2022 FY
Q3 2020 $85,287,324 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $112,669,915 30 Jun 2020 10-Q 10 Nov 2021 2021 Q3
Q4 2019 $106,917,585 31 Dec 2019 10-K 16 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.